NasdaqGS:DXCMMedical Equipment
DexCom (DXCM) Margin Improvement Challenges Cautious Narratives After Q1 2026 Earnings
DexCom (DXCM) opened 2026 with Q1 revenue of US$1.2b and basic EPS of US$0.52, set against trailing twelve month revenue of US$4.8b and EPS of US$2.39 that came with a net profit margin of 19.3% compared with 12.9% a year earlier. Over the past year, revenue has moved from US$4.0b to US$4.8b and EPS from US$1.46 to US$2.39, alongside earnings growth of 73.8% that analysts in the supplied data expect to continue. This puts the spotlight firmly on how durable these margins look after the latest...